You are here: Home » News » Technology Insight » Lenticular Filter in Pharmaceutical Manufacturing: USP Class VI Guide

Lenticular Filter in Pharmaceutical Manufacturing: USP Class VI Guide

Views: 67     Author: Site Editor     Publish Time: 2026-11-08      Origin: Site

Inquire

facebook sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button

When comparing lenticular filter manufacturers for a pharmaceutical process, identify the filtration duty and the evidence required for product-contact materials. A supplier's USP Class VI statement needs a report that identifies what was tested, the chapter edition and the test conditions. The purchasing decision also needs compatibility data and a trial showing that the selected assembly meets the process requirements.

Use our industrial buyer's guide to lenticular filters to organize the media and housing specification. Pharmaceutical qualification adds a documented assessment of the contact materials, product quality and supplier controls. The quality unit should define the evidence appropriate to the product, process stage and intended market.

Key takeaways

  • Read the material identity, test scope and edition behind a Class VI statement.

  • Assess all relevant product-contact components in the proposed flow path.

  • Evaluate chemical interaction and process performance alongside biological test data.

  • Define routine operating limits and supplier change notification before approval.

Define the filter's role in the manufacturing process

Write down the feed composition, process stage and separation target before selecting a grade. A clarification stage, an adsorptive treatment and protection of downstream equipment have different acceptance criteria. Specify the next stage and which quality attributes must be maintained across filtration.

For a process governed by US drug CGMP requirements, equipment-contact suitability includes its effect on product quality. Section 211.65 addresses the interaction of contact surfaces with materials and drug products. Apply that assessment to the proposed medium and assembly under their intended conditions of use. Document the process-specific assessment in the equipment qualification file.

LOONGFiltration's pharma and biotech application page provides an inquiry starting point. Request model-specific documentation for the filtration stage under review and submit it to the site's qualification process.

Read the report behind a USP Class VI claim

USP chapter <88> addresses biological reactivity testing of specified materials or their extracts. Its published versions have different scopes and test descriptions. Require the supplier to identify the edition and testing basis associated with any Class VI designation, then have QA assess its relevance to the proposed component. USP <88> biological-reactivity test description. Ask QA to compare the relevant chapter versions before accepting the report.

Report detail

Question for supplier review

Test article

Which resin, elastomer, medium or complete component was tested?

Identification

How does the report link to the material and part code being supplied?

Method

Which chapter edition, test procedures and extraction conditions were used?

Manufacturing state

Does the tested item represent the supplied and conditioned component?

Result and coverage

What conclusion does the laboratory report support for that test article?

Ask for the underlying report or the controlled supporting documentation agreed with QA. If a resin report is used to support a molded part, document how the supplier connects the evidence to that part. Keep the reasoning in the qualification file so a later material or manufacturing change can be assessed against it.

Lenticular Filter in Pharmaceutical Manufacturing USP Class VI Guide (3).png

Review the whole product-contact assembly

List the media, binders or filter aids where present, support structures, adapters and seals. Include the housing and any connected product-contact parts within the qualification boundary. Identify which component each document covers and where process-specific assessment is still needed.

USP <665> and <1665> address plastic components and systems used in pharmaceutical manufacturing and their characterization or qualification. Have QA document their applicability together with the relevant market requirements. USP's E&L resources place these manufacturing-system chapters alongside extractables and leachables assessments. Request the applicable chapter versions and supporting documents for the materials being proposed.

Consider the supplied condition and the preparation used before contact with product. Request the applicable rinse, sanitization or sterilization instructions and confirm that the qualification evidence supports the intended exposure. Record any restrictions in the approved lenticular filter procedure.

Lenticular Filter in Pharmaceutical Manufacturing USP Class VI Guide (4).png

Evaluate chemistry and recovery using the actual process liquid

Describe solvent composition, pH, contact time and temperature to the supplier. Ask for the compatibility evidence and chemical characterization data appropriate to those conditions. The assessment should address any substances that may enter the process stream and any product components that may be retained by the selected medium.

In the trial, measure the required impurity reduction and product recovery using methods appropriate to the process. Sample through the run so the result includes startup and the proposed endpoint. Define the quality attributes that must remain within their acceptance limits. This supplies process evidence for the contact-surface assessment required under the applicable quality system. Keep the contact-surface assessment with these production-trial results.

If a lenticular activated carbon filter is proposed, specify the adsorption target and assess recovery of the desired product. Request data for that exact formulation and liquid. LOONGFiltration lists several media families in its lenticular filter range, while its pure-cellulose module page identifies another media option for evaluation.

Set requirements for downstream quality controls

Define the particle, bioburden and other quality requirements at the selected filtration stage. For human injectable products manufactured under US requirements, 21 CFR 211.72 specifically addresses fiber release from liquid filters and the conditions for using an additional filter. Have the quality unit assess the proposed depth medium and downstream arrangement against that requirement. Record the proposed fiber-control arrangement in the site's qualification package.

Where the process uses sterilizing filtration, establish the final filter's validated retention performance, compatibility and integrity-testing program as part of the aseptic process. FDA's aseptic processing guidance addresses filter validation and integrity testing in that context. Include those controls in the process plan together with the upstream depth stage. FDA aseptic processing guidance

Set any endotoxin-related requirement as an explicit process endpoint with a suitable method and supporting performance study. A biological-reactivity report and a filtration challenge study answer different qualification questions and should have their own acceptance criteria in the file.

Compare suppliers using a controlled qualification package

Ask each supplier for the same process and documentation scope. The proposed lenticular filter media and housing should be identified by code, with operating limits linked to the selected configuration. Review fit and installation alongside the material assessment. Use our lenticular filter system setup checklist to define the mounting parts, instruments and supply responsibilities in the equipment inquiry.

Qualification area

Evidence to request

Component identity

Controlled part codes, contact-material list and drawings

Biological assessment

Applicable test reports with material, method and edition identified

Chemical interaction

Compatibility and extractables information relevant to intended use

Process performance

Trial protocol, recovery, impurity reduction and endpoint data

Routine operation

Preparation instructions, operating limits and replacement criteria

Supply lifecycle

Lot traceability, document revision control and change notification arrangements

Agree on how changes to material formulation, assembly or manufacturing location will be communicated and assessed. Keep the approved configuration tied to the trial record. When transferring lenticular filter operation to production, verify that the installed parts and operating procedure match the approved package.

Lenticular Filter in Pharmaceutical Manufacturing USP Class VI Guide (1).png

Frequently asked questions

Does every part need the same USP Class VI report?

QA should define the appropriate evidence for each contact material and component. Require the supplier to identify the test article and the scope of its report so the qualification can connect the evidence to the parts being purchased.

Can a raw-material report support a complete module?

It can contribute to the assessment where its relationship to the supplied component is documented. Review the other materials, processing and intended conditions of use as part of the complete qualification.

Is Class VI evidence sufficient to qualify a sterilizing filter?

Sterilizing filtration needs performance validation and routine controls appropriate to the process, including integrity testing. Keep that evidence in the final filtration qualification alongside the material assessment. Keep the validated final-filtration controls documented separately.

What should I send when requesting a pharmaceutical module proposal?

Provide the process stage, liquid composition and contact conditions, the separation target and product-recovery criteria. Include the required documentation scope and existing housing information. Ask the supplier to identify any evidence requiring further process-specific assessment.

Request a documented filtration proposal

Send LOONGFiltration your process duty and qualification requirements. Include the current module or housing drawing if you are evaluating a replacement. Request the proposed part identification and available supporting documents so your technical and quality teams can review the configuration together. Discuss pharmaceutical filtration requirements. You can also visit the LOONGFiltration website or browse the official YouTube channel.

Table of Content
Leave a comment if you are interested.
Welcome your message, we will reply you within 24 hours. In addition, your email will not be displayed.​​​​​​​
INQUIRY
A SPECIALIST IN FILTRATION EXCELLENCE!

 Tel: +86-571-26232618
 WhatsApp: +8619558243921
 Email:
sales@loongfiltration.com
Address: 19.Building 12, No. 42, Tianhe Road, Donghu Street, Linping, Hangzhou, Zhejiang,P.R. China

COMPANY

PRODUCT

APPLICATION

Copyright 2025 LOONG FILTRATION All Rights Reserved. Sitemap | Privacy Policy